Cite
HARVARD Citation
Sáez-Llorens, X. et al. (2018). Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. Lancet infectious diseases. 18 (2), pp. 162-170. [Online].